Piotr Waloszczyk

1.6k total citations · 1 hit paper
32 papers, 921 citations indexed

About

Piotr Waloszczyk is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Piotr Waloszczyk has authored 32 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Piotr Waloszczyk's work include Occupational and environmental lung diseases (5 papers), RNA modifications and cancer (3 papers) and BRCA gene mutations in cancer (2 papers). Piotr Waloszczyk is often cited by papers focused on Occupational and environmental lung diseases (5 papers), RNA modifications and cancer (3 papers) and BRCA gene mutations in cancer (2 papers). Piotr Waloszczyk collaborates with scholars based in Poland, United States and Japan. Piotr Waloszczyk's co-authors include Jerzy Lasota, Markku Miettinen, Wojciech Biernat, Piotr Czapiewski, Renata Langfort, Zengfeng Wang, Janusz Ryś, Peter A. McCue, Maarit Sarlomo‐Rikala and Kazimierz Ciechanowski and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and The American Journal of Surgical Pathology.

In The Last Decade

Piotr Waloszczyk

30 papers receiving 908 citations

Hit Papers

GATA3 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Waloszczyk Poland 14 447 358 201 184 128 32 921
Renato Colella Italy 17 285 0.6× 261 0.7× 266 1.3× 185 1.0× 128 1.0× 40 847
Libero Ciuffreda Italy 21 271 0.6× 780 2.2× 308 1.5× 296 1.6× 140 1.1× 63 1.3k
Feng Zhan China 18 281 0.6× 318 0.9× 146 0.7× 422 2.3× 215 1.7× 68 1.0k
Atsushi Osoegawa Japan 17 390 0.9× 587 1.6× 130 0.6× 334 1.8× 177 1.4× 88 1.1k
Jędrzej Grzegrzółka Poland 18 169 0.4× 427 1.2× 87 0.4× 466 2.5× 259 2.0× 76 1.1k
Leticia Esparza Spain 13 176 0.4× 348 1.0× 286 1.4× 131 0.7× 183 1.4× 26 809
Sung Mo Hur South Korea 17 231 0.5× 223 0.6× 315 1.6× 203 1.1× 219 1.7× 43 981
Ramamoorthy Nagasubramanian United States 11 437 1.0× 365 1.0× 67 0.3× 357 1.9× 181 1.4× 31 1.1k
Nezih Meydan Türkiye 15 184 0.4× 323 0.9× 62 0.3× 105 0.6× 88 0.7× 44 639
Salvatore Di Lauro Italy 16 209 0.5× 231 0.6× 166 0.8× 303 1.6× 116 0.9× 54 1.1k

Countries citing papers authored by Piotr Waloszczyk

Since Specialization
Citations

This map shows the geographic impact of Piotr Waloszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Waloszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Waloszczyk more than expected).

Fields of papers citing papers by Piotr Waloszczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Waloszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Waloszczyk. The network helps show where Piotr Waloszczyk may publish in the future.

Co-authorship network of co-authors of Piotr Waloszczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Waloszczyk. A scholar is included among the top collaborators of Piotr Waloszczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Waloszczyk. Piotr Waloszczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Inaguma, Shingo, Jerzy Lasota, Masayuki Komura, et al.. (2023). CD70 and PD‐L1 (CD274) co‐expression predicts poor clinical outcomes in patients with pleural mesothelioma. The Journal of Pathology Clinical Research. 9(3). 195–207. 4 indexed citations
3.
Lasota, Jerzy, Artur Kowalik, Anna Felisiak-Gołąbek, et al.. (2019). Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors. Modern Pathology. 32(7). 957–966. 20 indexed citations
4.
Sukiennicki, Grzegorz, Wojciech Marciniak, Magdalena Muszyńska, et al.. (2019). Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence. PLoS ONE. 14(1). e0208610–e0208610. 48 indexed citations
5.
Wojtyś, Małgorzata, Agnieszka Piekarska, Michał Kunc, et al.. (2019). Clinicopathological comparison and therapeutic approach to Castleman disease—a case-based review. Journal of Thoracic Disease. 11(11). 4859–4874. 13 indexed citations
6.
Inaguma, Shingo, Jerzy Lasota, Piotr Czapiewski, et al.. (2019). CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness. The Journal of Pathology. 250(2). 205–216. 33 indexed citations
7.
Pieróg, Jarosław, Janusz Wójcik, Bartosz Kubisa, et al.. (2018). Evaluation of the metabolic response to open and minimally invasive resection of the oesophagus due to oesophageal cancer. Polish Journal of Cardio-Thoracic Surgery. 15(3). 151–156. 1 indexed citations
8.
Lasota, Jerzy, Artur Kowalik, Anna Felisiak-Gołąbek, et al.. (2017). SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma. Archives of Pathology & Laboratory Medicine. 141(4). 564–568. 8 indexed citations
9.
Inaguma, Shingo, Jerzy Lasota, Zengfeng Wang, et al.. (2017). Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma. Human Pathology. 71. 1–7. 43 indexed citations
10.
Durda, Katarzyna, Satish Gupta, Michał Szydłowski, et al.. (2017). Serum folate concentration and the incidence of lung cancer. PLoS ONE. 12(5). e0177441–e0177441. 29 indexed citations
11.
Menkiszak, Janusz, Victoria Sopik, Anita Chudecka-Głaz, et al.. (2016). The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania. Clinical Genetics. 91(2). 322–327. 2 indexed citations
12.
Gupta, Satish, Katarzyna Durda, Grzegorz Sukiennicki, et al.. (2013). Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers. PLoS ONE. 8(8). 16 indexed citations
13.
Miettinen, Markku, Maarit Sarlomo‐Rikala, Peter A. McCue, et al.. (2013). Mapping of Succinate Dehydrogenase Losses in 2258 Epithelial Neoplasms. Applied immunohistochemistry & molecular morphology. 22(1). 31–36. 32 indexed citations
14.
Miettinen, Markku, Peter A. McCue, Maarit Sarlomo‐Rikala, et al.. (2013). GATA3. The American Journal of Surgical Pathology. 38(1). 13–22. 469 indexed citations breakdown →
15.
Waloszczyk, Piotr, et al.. (2012). Estimation of BDNF gene polymorphism and predisposition to dependence development for selected psychoactive compounds. Human & Experimental Toxicology. 32(3). 236–240. 6 indexed citations
17.
Waloszczyk, Piotr, et al.. (2008). Choroba Menkesa – genetyczny defekt metabolizmu miedzi. 17(33). 63–68. 1 indexed citations
18.
Cybulski, Cezary, Dorota Oszutowska–Mazurek, Ewa Jaworowska, et al.. (2008). Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers. Carcinogenesis. 29(4). 762–765. 35 indexed citations
19.
Machoy‐Mokrzyńska, Anna, et al.. (2006). Psilocin multiple intake resulted and in cardiotoxic effects. 14. 2 indexed citations
20.
Waloszczyk, Piotr, et al.. (2000). [Morphology of a lithic lesion of the bone treated with cement filling with the addition of methotrexate].. PubMed. 65(1). 87–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026